ORAGENICS, INC. Prepaid Expense and Other Assets, Current
ORAGENICS, INC. (OGEN) had Prepaid Expense and Other Assets, Current of $1.63 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Prepaid Expense and Other Assets, Current $1.63M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $1.38M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $1.61M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $1.30M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.63M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.38M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $1.61M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $1.30M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $1.30M 10-Q · filed 2025-11-07 | $165.96K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $448.03K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $607.67K 10-K · filed 2026-03-16 | |
| 2024-09-30 | $969.29K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $270.33K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $371.21K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $382.27K 10-K · filed 2025-03-14 | |
| 2023-09-30 | $2.01M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.61M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $2.54M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $2.86M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $2.57M 10-Q/A · filed 2023-04-14 | $561.95K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.99M 10-Q/A · filed 2023-04-14 | $102.50K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.72M 10-Q/A · filed 2023-04-14 | $277.47K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $434.70K 10-K · filed 2023-04-17 | |
| 2021-09-30 | $586.52K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $86.92K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $222.79K 10-Q · filed 2021-05-03 | |
| 2020-12-31 | $343.11K 10-K/A · filed 2022-07-29 | |
| 2020-09-30 | $485.65K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $295.49K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $328.67K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $570.07K 10-K · filed 2021-03-01 | |
| 2019-09-30 | $555.47K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $355.41K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $1.72M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $1.72M 10-K · filed 2020-03-04 | |
| 2018-09-30 | $1.66M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $1.26M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $722.63K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $1.03M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $769.63K 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $517.73K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $106.31K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $141.09K 10-K · filed 2018-02-16 | |
| 2016-09-30 | $171.87K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $111.83K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $192.89K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $209.30K 10-K · filed 2017-02-27 | $211.75K 10-K · filed 2016-03-30 |
| 2015-09-30 | $173.25K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $90.39K 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $133.79K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $119.41K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $221.64K 10-Q · filed 2014-11-03 | |
| 2014-06-30 | $144.57K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $154.36K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $175.24K 10-K · filed 2015-02-27 | |
| 2013-09-30 | $227.01K 10-Q · filed 2013-10-25 | |
| 2013-06-30 | $302.40K 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $210.50K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $221.84K 10-K · filed 2014-02-28 | |
| 2012-09-30 | $236.40K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $152.33K 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $123.85K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $113.33K 10-K · filed 2013-03-26 | |
| 2011-09-30 | $168.26K 10-Q · filed 2011-11-14 | |
| 2010-12-31 | $139.88K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |